Progesterone level and response to oxytocin at term.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 4175417)

Published in Lancet on September 07, 1968

Authors

E D Johansson

Articles by these authors

(truncated to the top 100)

Induction of sex hormone binding globulin by phenytoin. Br Med J (1977) 2.13

Progesterone levels in peripheral plasma during the luteal phase of the normal human menstrual cycle measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 1.75

Depression of the progesterone levels in women treated with synthetic gestagens after ovulation. Acta Endocrinol (Copenh) (1971) 1.57

The effect of various dosages of lynestrenol on the plasma levels of oestrogens and progesterone during the menstrual cycle in the rhesus monkey. Contraception (1976) 1.47

Plasma levels of progesterone after vaginal, rectal, or intramuscular administration of progesterone. Am J Obstet Gynecol (1971) 1.38

Radioimmunoassay of oestrone and oestradiol in human and bovine peripheral plasma. Acta Endocrinol (Copenh) (1972) 1.12

Relationship between the plasma levels of luteinizing hormone and progesterone during the normal menstrual cycle. J Clin Endocrinol Metab (1967) 1.09

Plasma levels of medroxyprogesterone acetate (MPA), sex-hormone binding globulin, gonadal steroids, gonadotrophins and prolactin in women during long-term use of depo-MPA (Depo-Provera) as a contraceptive agent. Acta Endocrinol (Copenh) (1982) 1.04

Practice and patterns of estrogen treatment in climacteric women in a Swedish population. A descriptive epidemiological study. Part I. Acta Obstet Gynecol Scand (1983) 1.02

Plasma levels of nonconjugated oestrone, oestradiol-17beta and oestriol during uncomplicated pregnancy. Acta Obstet Gynecol Scand Suppl (1974) 0.97

Effects of continuous daily administration of 0.03 mg of d-norgestrel on the plasma levels of progesterone and the urinary excretion of oestrogens. Acta Endocrinol (Copenh) (1971) 0.96

Periovulatory progesterone concentration in the peripheral plasma of the rhesus monkey with a methodologic note on the detection of ovulation. Endocrinology (1968) 0.95

Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Ups J Med Sci (1979) 0.95

Oral contraceptives after intestinal bypass operations. JAMA (1976) 0.93

Luteinizing hormone (LH) and progesterone in plasma and LH and oestrogens in urine during 42 normal menstrual cycles. Acta Endocrinol (Copenh) (1971) 0.93

Plasma levels of progesterone in pregnancy measured by a rapid competitive protein binding technique. Acta Endocrinol (Copenh) (1969) 0.92

Sex hormone binding globulin: the carrier protein for d-norgestrel. J Clin Endocrinol Metab (1976) 0.92

Menstruation span--a time-limited risk factor for endometrial carcinoma. Acta Obstet Gynecol Scand (1986) 0.90

The risk of endometrial neoplasia and treatment with estrogens and estrogen-progestogen combinations. First results of a cohort study after one to four completed years of observation. Acta Obstet Gynecol Scand (1986) 0.90

Radioimmunological methods for the estimation of oestrone, oestradiol-17beta and oestriol in pregnancy plasma. Acta Obstet Gynecol Scand Suppl (1974) 0.89

Monophasic basal body temperature in ovulatory menstrual cycles. Am J Obstet Gynecol (1972) 0.87

A simplified procedure for the assay of progesterone. Acta Endocrinol Suppl (Copenh) (1970) 0.86

Lack of clinical contraceptive efficacy of large doses of r 2323 given before implantation or after a missed period. Contraception (1975) 0.86

The influence of conjugated estrogens in radioimmunoassays using different antibodies against estradiol-17beta. Steroids (1973) 0.86

Characteristics of estrogen-treated women. A descriptive epidemiological study of a Swedish population. Part II. Acta Obstet Gynecol Scand (1983) 0.85

Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy. Br J Obstet Gynaecol (1978) 0.84

Plasma levels of estrogens during long-term treatment with depo-medroxyprogesterone acetate as a contraceptive agent. Contraception (1973) 0.84

The influence of norethisterone oenanthate on ovarian function. Acta Endocrinol (Copenh) (1976) 0.84

Observations on the antigenicity and clinical effects of a candidate antipregnancy vaccine: beta-subunit of human chorionic gonadotropin linked to tetanus toxoid. Fertil Steril (1980) 0.83

Patterns of circulating progesterone concentrations during the fertile menstrual cycle and the remainder of gestation in the rhesus monkey. Endocrinology (1969) 0.83

Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Br J Obstet Gynaecol (1980) 0.83

Transfer of estradiol to human milk. Am J Obstet Gynecol (1978) 0.82

A D-norgestrel-releasing IUD. Contraception (1976) 0.82

Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel. Contraception (1976) 0.82

Ovarian function during use of a levonorgestrel-releasing IUD. Contraception (1990) 0.81

Serum estrogens and androgens in women with endometrial carcinoma. Gynecol Oncol (1986) 0.81

Periovulatory levels of plasma progesterone and luteinizing hormone in women. Acta Endocrinol (Copenh) (1969) 0.81

Endometrial histology and circulating levels of medroxyprogesterone acetate (MPA), estradiol, FSH and LH in women with MPA induced amenorrhoea compared with women with secondary amenorrhoea. Acta Obstet Gynecol Scand (1977) 0.81

Evaluation of the prognosis of threatened abortion from the peripheral plasma levels of progesterone, estradiol, and human chorionic gonadotropin. Am J Obstet Gynecol (1973) 0.80

Peripheral plasma levels of oestrone and progesterone in pregnant cows treated with dexamethasone. Acta Endocrinol (Copenh) (1972) 0.80

Premature onset of menstrual bleeding during ovulatory cycles in women with an intrauterine contraceptive device. Am J Obstet Gynecol (1973) 0.80

Influence of hypophysectomy, sham hypophysectomy and other surgical procedures on luteal function in the rhesus monkey. Endocrinology (1968) 0.79

The sterile menstrual cycle. The driving force behind pathology in the reproductive organs. Acta Obstet Gynecol Scand Suppl (1984) 0.79

Peripheral plasma levels of oestrogens and progesterone during late bovine pregnancy. Acta Endocrinol (Copenh) (1973) 0.79

Peripheral plasma levels of 17 -hydroxyprogesterone, progesterone and oestradiol during normal menstrual cycles in women. Acta Endocrinol (Copenh) (1972) 0.79

Plasma levels of progesterone and oestrogens in women treated with an oral contraceptive of low oestrogen content (Ovostat 1375). Acta Obstet Gynecol Scand (1975) 0.79

Clearance of levonorgestrel from the circulation following removal of NORPLANT subdermal implants. Contraception (1988) 0.79

Plasma levels of levonorgestrel in women during longterm use of norplant. Contraception (1981) 0.79

Levonorgestrel plasma levels during continuous administration with different models of subdermal implants. Contraception (1983) 0.79

Sialic acid content and sperm penetration of cervical mucus in relation to total urinary oestrogen excretion and plasma progesterone levels in ovulatory women. Acta Endocrinol (Copenh) (1969) 0.79

Plasma levels of levonorgestrel and free levonorgestrel index in women using NORPLANT implants or two covered rods (NORPLANT-2). Contraception (1987) 0.78

Blood plasma levels of progesterone and oestradiol in the dog during the oestrous cycle and pregnancy. Acta Endocrinol (Copenh) (1975) 0.78

Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin). Br J Obstet Gynaecol (1978) 0.78

Absorption of an oral contraceptive gestagen in ulcerative colitis before and after proctocolectomy and construction of a continent ileostomy. Contraception (1985) 0.78

Pharmacokinetic observations on medroxyprogesterone acetate administered orally and intravaginally. Contraception (1976) 0.78

Contraception with NORPLANT implants and NORPLANT-2 implants (two covered rods). Results from a comparative clinical study in Sweden. Contraception (1988) 0.78

Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles. Contraception (1976) 0.78

Levels of progesterone in peripheral plasma during the menstrual cycle of the rhesus monkey. Endocrinology (1967) 0.78

Relation between sex hormone binding globulin and D-norgestrel levels in plasma. Acta Endocrinol (Copenh) (1977) 0.78

Endocrine changes before and after the menarche. I. Urinary excretion of estrogen, FSH and LH, and serum levels of progesterone, FSH and LH. Acta Obstet Gynecol Scand (1974) 0.78

Plasma levels of norethindrone after single oral dose administration of norethindrone and lynestrenol. Clin Endocrinol (Oxf) (1979) 0.78

Plasma levels of medroxyprogesterone acetate (MPA), estradiol and progesterone in the rhesus monkey after intramuscular adminstration of Depo-Provera. Contraception (1976) 0.78

A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings. Contraception (2000) 0.78

Effect of HCG on plasma levels of estrogens and progesterone during the luteal phase of the menstrual cycle in rhesus monkeys (Macaca mulatta). Stimulation of sex steroid production in Rhesus monkeys. Int J Fertil (1974) 0.78

Assessment of placental function in uncomplicated and complicated late pregnancy by estimation of unconjugated oestrogens in plasma after an intravenous injection of dehydroepiandrosterone sulphate. Acta Endocrinol (Copenh) (1978) 0.77

Treatment of primary amenorrhoea with human pituitary and chorionic gonadotrophins. J Obstet Gynaecol Br Commonw (1970) 0.77

Progesterone levels in amniotic fluid and plasma from women. I. Levels during normal pregnancy. Acta Obstet Gynecol Scand (1971) 0.77

Medroxyprogesterone acetate pharmacokinetics following oral high-dose administration in humans: a bioavailability evaluation of a new MPA tablet formulation. Acta Pharmacol Toxicol (Copenh) (1986) 0.77

Ethinyl estradiol in human milk and plasma after oral administration. Contraception (1978) 0.76

Peripheral plasma levels of oestrogens, progesterone and 17alpha-hydroxyprogesterone during gestation in the rhesus monkey. Acta Endocrinol (Copenh) (1973) 0.76

Bioavailability of oestriol. Acta Endocrinol (Copenh) (1982) 0.76

Peripheral plasma levels of oestrone, oestradiol-17beta and progesterone during ovulatory menstrual cycles in the rhesus monkey with special reference to the onset of menstruation. Acta Endocrinol (Copenh) (1973) 0.76

The plasma concentration of medroxyprogesterone acetate and ovarian function during treatment with medroxyprogesterone acetate in 5 and 10 mg doses. Acta Obstet Gynecol Scand (1984) 0.76

The effect of oxytocin on the complication rate of early therapeutic abortions. Acta Obstet Gynecol Scand (1970) 0.76

Medroxyprogesterone acetate (MPA) plasma levels after oral and intramuscular administration in a long-term study. Acta Obstet Gynecol Scand Suppl (1981) 0.76

The effect of progestin R 2323 released from vaginal rings on ovarian function. Contraception (1975) 0.76

Peripheral plasma levels of oestrogens, progesterone and 17 -hydroxyprogesterone during the menstrual cycle of the rhesus monkey. Acta Endocrinol (Copenh) (1972) 0.75

Long-term follow-up of women treated with Norplant implants. Contraception (1987) 0.75

Postovulatory contraception in women with large doses of norethindrone. Contraception (1972) 0.75

Plasma protein binding of norethisterone. Contraception (1982) 0.75

Failure of hysterectomy to influence the normal pattern of cyclic progesterone secretion in the rhesus monkey. Endocrinology (1969) 0.75

Bleeding pattern, outcome of accidental pregnancies and levonorgestrel plasma levels associated with method failure in Norplant implants users. Contraception (1986) 0.75

Serum lipoprotein and apolipoprotein changes during treatment with a contraceptive vaginal ring containing levonorgestrel and estradiol. Acta Obstet Gynecol Scand (1982) 0.75

Effects of continuous levonorgestrel treatment (subcutaneous capsules) on the lipoprotein and carbohydrate metabolism in fertile women. Ups J Med Sci (1983) 0.75

Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel. Contraception (1985) 0.75

Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins. Contraception (1981) 0.75

Absorption of topically applied hydrocortisone from the eye of the rhesus monkey. Acta Ophthalmol (Copenh) (1982) 0.75

Influence of food on oestriol blood levels. Maturitas (1984) 0.75

Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST-1435. Contraception (1982) 0.75

Oral versus vaginal absorption in oestradiol in postmenopausal women. Effects of different particles sizes. Ups J Med Sci (1981) 0.75

Ovarian function, bleeding control and serum lipoproteins in women using contraceptive vaginal rings releasing five different progestins. Contraception (1983) 0.75

Effects of Epostane on progesterone synthesis in early human pregnancy. Contraception (1986) 0.75

Combined and sequential oral contraceptives and progesterone. Lancet (1969) 0.75

Contraceptive strategies for young women in the 21st century. Eur J Contracept Reprod Health Care (1999) 0.75

Ovarian function during treatment with high ratio levonorgestrel/ethinyl estradiol as oral contraceptives. Gynecol Obstet Invest (1982) 0.75

Effect of sulfasalazine and its analogs on fertility in male rats. Contraception (1988) 0.75

The cost of the menstrual cycle in young Swedish women. Eur J Contracept Reprod Health Care (2000) 0.75

Effects of oestradiol on sex hormone binding globulin. Acta Endocrinol (Copenh) (1982) 0.75

Climacteric symptoms and estrogen replacement therapy in women with endometrial carcinoma. Acta Obstet Gynecol Scand (1986) 0.75

High affinity specific monoclonal antibodies against progesterone. Indian J Med Res (1987) 0.75